StocksBiogen IncBIIB

BIIB

Biogen Inc

388.44 4.92 (1.28%)
Precios retrasados ofrecidos por el índice NASDAQ, en USD Mercado cerrado
Invertir
V
387.66
C
388.70

Biogen Inc

Biogen Idec es una empresa biofarmacéutica global centrada en descubrir, desarrollar, fabricar y ofrecer tratamientos para trastornos neurológicos, autoinmunes y hematológicos.
Último mes
42,767
Seguidores
0.42%
Inversores
91% Of them have BUY positions.
A decrease of -1.41% from last trading Day

Mercados relacionados

Baxter International Inc
BAX
-0.33 (-0.41%)
V
80.67
C
80.90
Amplifon
AMP.MI
-0.66 (-1.60%)
V
40.18
C
40.27
Medtronic PLC
MDT
-1.98 (-1.58%)
V
123.10
C
123.35
Waters Corporation
WAT
-3.85 (-1.11%)
V
342.33
C
343.24
Seattle Genetics
SGEN
2.93 (1.91%)
V
156.07
C
156.41
Ver más
Publicación incluida
Editado
Pietro Lavisci
BIOGEN valuation updated with ADUHELM coming in the pipeline 🧪 📓As from Monday, 7th June, the FDA approved the molecule Aducanumab (branded as ADUHELM) for the treatment of Alzheimer’s disease under a quicker than usual pathway generally reserved for oncologic drugs (the Accelerated Approval pathway). Aduhelm... Mostrar más Traducir
Canal de mercado
Destacado
Konstantinos Kousouris
Brief news - Biggest moves pre-market 18/06/2021 $ADBE (Adobe Systems Inc) Adobe reported quarterly profit of $3.03 per share, 21 cents a share above estimates. The software company’s revenue also topped Wall Street forecasts and Adobe gave stronger-than-expected current-quarter guidance. Its shares... Mostrar más Traducir
Andrea Antico
MOVERS Ocugen $OCGN (Ocugen Inc) rises after selecting Jubilant HollisterStier as its manufacturing partner for COVAXIN to prepare for the potential commercial manufacturing of the COVID-19 vaccine for the U.S. and Canadian markets Elanco $ELAN (Elanco Animal Health Inc) gains after selling two facilities... Mostrar más Traducir
Me gusta ComentarCompartir